Your browser doesn't support javascript.
loading
Impact of Transjugular Intracardiac Echocardiography-Guided Self-Expandable Transcatheter Aortic Valve Implantation on Reduction of Conduction Disturbances.
Ishizu, Kenichi; Shirai, Shinichi; Miyawaki, Norihisa; Nakano, Kenji; Fukushima, Tadatomo; Ko, Euihong; Tsuru, Yasuo; Tashiro, Hiroaki; Tabata, Hiroyuki; Nakamura, Miho; Morofuji, Toru; Morinaga, Takashi; Hayashi, Masaomi; Isotani, Akihiro; Ohno, Nobuhisa; Kakumoto, Shinichi; Ando, Kenji.
Affiliation
  • Ishizu K; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Shirai S; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Miyawaki N; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Nakano K; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Fukushima T; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Ko E; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Tsuru Y; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Tashiro H; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Tabata H; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Nakamura M; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Morofuji T; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Morinaga T; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Hayashi M; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Isotani A; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Ohno N; Department of Cardiovascular Surgery (N.O.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Kakumoto S; Department of Anesthesiology (S.K.), Kokura Memorial Hospital, Kitakyushu, Japan.
  • Ando K; Department of Cardiology (K.I., S.S., N.M., K.N., T.F., E.K., Y.T., H. Tashiro, H. Tabata, M.N., T. Morofuji, T. Morinaga, M.H., A.I., K.A.), Kokura Memorial Hospital, Kitakyushu, Japan.
Circ Cardiovasc Interv ; 17(2): e013094, 2024 02.
Article in En | MEDLINE | ID: mdl-38152879
ABSTRACT

BACKGROUND:

A high permanent pacemaker implantation (PPI) risk remains a concern of self-expandable transcatheter aortic valve implantation, despite the continued improvements in implantation methodology. We aimed to assess the impact of real-time direct visualization of the membranous septum using transjugular intracardiac echocardiography (ICE) during transcatheter aortic valve implantation on reducing the rates of conduction disturbances including the need for PPI.

METHODS:

Consecutive patients treated with Evolut R and Evolut PRO/PRO+ from February 2017 to September 2022 were included in this study. We compared outcomes between the conventional implantation method using the 3-cusps view (3 cusps without ICE group), the recent method using cusp-overlap view (cusp overlap without ICE group), and our novel method using ICE (cusp overlap with ICE group).

RESULTS:

Of the 446 patients eligible for analysis, 211 (47.3%) were categorized as the 3 cusps without ICE group, 129 (28.9%) were in the cusp overlap without ICE group, and 106 (23.8%) comprised the cusp overlap with ICE group. Compared with the 3 cusps without ICE group, the cusp overlap without ICE group had a smaller implantation depth (2.2 [interquartile range, 1.0-3.5] mm versus 4.3 [interquartile range, 3.3-5.4] mm; P<0.001) and lower 30-day PPI rates (7.0% versus 14.2%; P=0.035). Compared with the cusp overlap without ICE group, the cusp overlap with ICE group had lower 30-day PPI rates (0.9%; P=0.014), albeit with comparable implantation depths (1.9 [interquartile range, 0.9-2.9] mm; P=0.150). Multivariable analysis showed that our novel method using ICE with the cusp-overlap view was independently associated with a 30-day PPI rate reduction. There were no group differences in 30-day all-cause mortality (1.4% versus 1.6% versus 0%; P=0.608).

CONCLUSIONS:

Our novel implantation method using transjugular ICE, which enable real-time direct visualization of the membranous septum, achieved a predictably high position of prostheses, resulting in a substantial reduction of conduction disturbances requiring PPI after transcatheter aortic valve implantation.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aortic Valve Stenosis / Pacemaker, Artificial / Heart Valve Prosthesis / Transcatheter Aortic Valve Replacement Limits: Humans Language: En Journal: Circ Cardiovasc Interv / Circ., cariovasc. interv. (Print) / Circulation. cardiovascular interventions (Print) Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2024 Type: Article Affiliation country: Japan

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aortic Valve Stenosis / Pacemaker, Artificial / Heart Valve Prosthesis / Transcatheter Aortic Valve Replacement Limits: Humans Language: En Journal: Circ Cardiovasc Interv / Circ., cariovasc. interv. (Print) / Circulation. cardiovascular interventions (Print) Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2024 Type: Article Affiliation country: Japan